Nopporn Chutiwitoonchai

Dr. Nopporn Chutiwitoonchai

Virology and Cell Technology Research Team, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA)
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in Microbes and Infection
Verified
Journal Article
Closed access
NCNopporn Chutiwitoonchai
Nopporn Chutiwitoonchai
MHMasateru Hiyoshi
Masateru Hiyoshi
YHYuka Hiyoshi-Yoshidomi
Yuka Hiyoshi-Yoshidomi
MHMichihiro Hashimoto
Michihiro Hashimoto
KTKenzo Tokunaga
Kenzo Tokunaga
SSShinya Suzu
Shinya Suzu

7 December 2021 in Foods
Verified
Journal Article
Open access
PDF file
MAMaharani Ajeng Astiti
Maharani Ajeng Astiti
AJAkanitt Jittmittraphap
Akanitt Jittmittraphap
PLPornsawan Leaungwutiwong
Pornsawan Leaungwutiwong
NCNopporn Chutiwitoonchai
Nopporn Chutiwitoonchai
PPPatcharee Pripdeevech
Patcharee Pripdeevech
PKPrasat Kittakoop
Prasat Kittakoop
Coccinia grandis or ivy gourd is an edible plant. Its leaves and fruits are used as vegetable in many countries. Many works on antidiabetic activity of a crude extract of C. grandis, i.e., in vitro, in vivo, and clinical trials studies, have been reported. Profiles of the antidiabetic compounds were previously proposed by using LC-MS or GC-MS. However, the compounds responsible for antidiabetic activity have rarely been isolated and characterized by analysis of 1D and 2D NMR data. In the present work, UHPLC-ESI-QTOF-MS/MS analysis and GNPS molecular networking were used to guide the isolation of α-glucosidase inhibitors from an extract of C. grandis leaves. Seven flavonoid glycosides including rutin (1), kaempferol 3-O-rutinoside (2) or nicotiflorin, kaempferol 3-O-robinobioside (3), quercetin 3-O-robinobioside (4), quercetin 3-O-β-D-apiofuranosyl-(1→2)-[α-L-rhamnopyranosyl-(1→6)]-β-D-glucopyranoside (5) or CTN-986, kaempferol 3-O-β-D-api-furanosyl-(1→2)-[α-L-rhamnopyranosyl-(1→6)]-β-D-glucopyranoside (6), and kaempferol 3-O-β-D-apiofuranosyl-(1→2)-[α-L-rhamnopyranosyl-(1→6)]-β-D-galactopyranoside (7) were isolated from C. grandis leaves. This is the first report of glycosides containing apiose sugar in the genus Coccinia. These glycosides exhibited remarkable α-glucosidase inhibitory activity, being 4.4–10.3 times more potent than acarbose. Moreover, they also displayed virucidal activity against influenza A virus H1N1, as revealed by the ASTM E1053-20 method.

1 December 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
KAKhent Primo Alcantara
Khent Primo Alcantara
NNNonthaneth Nalinratana
Nonthaneth Nalinratana
NCNopporn Chutiwitoonchai
Nopporn Chutiwitoonchai
ACAgnes Castillo
Agnes Castillo
WBWijit Banlunara
Wijit Banlunara
PRPornchai Rojsitthisak
Pornchai Rojsitthisak
Favipiravir (FVR) is a repurposed antiviral drug for treating mild to moderate cases of the novel coronavirus disease 2019 (COVID-19). However, its poor solubility and permeability limit its clinical efficacy. To overcome its physicochemical and pharmacokinetic limitations, we statistically designed a mucoadhesive chitosan–alginate nanoparticles (MCS-ALG-NPs) as a new carrier for FVR using response surface methodology, which provided suitable characteristics for transmucosal delivery. The use of mucoadhesive polymers for intranasal administration promotes the residence time and contact of FVR in the mucus membrane. The optimized FVR-MCS-ALG-NPs demonstrated superior mucoadhesion, higher permeation and deposition in the nasal mucosa, and a significant increase in the inhibition of viral replication over 35-fold compared with free FVR. The overall results suggest that MCS-ALG-NPs could be used as an effective mucoadhesive carrier to enhance the activity of FVR against COVID-19.

10 June 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SSSanya Sureram
Sanya Sureram
NCNopporn Chutiwitoonchai
Nopporn Chutiwitoonchai
TPTam Pooprasert
Tam Pooprasert
WSWatchara Sangsopha
Watchara Sangsopha
SLSuphitcha Limjiasahapong
Suphitcha Limjiasahapong
PKPrasat Kittakoop
Prasat Kittakoop

15 November 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NCNopporn Chutiwitoonchai
Nopporn Chutiwitoonchai
MHMasateru Hiyoshi
Masateru Hiyoshi
PMPhilip Mwimanzi
Philip Mwimanzi
TUTakamasa Ueno
Takamasa Ueno
AAAkio Adachi
Akio Adachi
SSShinya Suzu
Shinya Suzu
Nef is a multifunctional HIV-1 protein that accelerates progression to AIDS, and enhances the infectivity of progeny viruses through a mechanism that is not yet understood. Here, we show that the small molecule compound 2c reduces Nef-mediated viral infectivity enhancement. When added to viral producer cells, 2c did not affect the efficiency of viral production itself. However, the infectivity of the viruses produced in the presence of 2c was significantly lower than that of control viruses. Importantly, an inhibitory effect was observed with Nef+ wild-type viruses, but not with viruses produced in the absence of Nef or in the presence of proline-rich PxxP motif-disrupted Nef, both of which displayed significantly reduced intrinsic infectivity. Meanwhile, the overexpression of the SH3 domain of the tyrosine kinase Hck, which binds to a PxxP motif in Nef, also reduced viral infectivity. Importantly, 2c inhibited Hck SH3-Nef binding, which was more marked when Nef was pre-incubated with 2c prior to its incubation with Hck, indicating that both Hck SH3 and 2c directly bind to Nef and that their binding sites overlap. These results imply that both 2c and the Hck SH3 domain inhibit the interaction of Nef with an unidentified host protein and thereby reduce Nef-mediated infectivity enhancement. The first inhibitory compound 2c is therefore a valuable chemical probe for revealing the underlying molecular mechanism by which Nef enhances the infectivity of HIV-1.

1 July 2017 in Virology
Verified
Journal Article
Closed access
NCNopporn Chutiwitoonchai
Nopporn Chutiwitoonchai
TMTakafumi Mano
Takafumi Mano
MKMichinori Kakisaka
Michinori Kakisaka
HSHirotaka Sato
Hirotaka Sato
YKYasumitsu Kondoh
Yasumitsu Kondoh
YAYoko Aida
Yoko Aida